BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32296013)

  • 41. Targeting BCL10 by small peptides for the treatment of B cell lymphoma.
    Bao W; Sun C; Sun X; He M; Yu H; Yan W; Wen F; Zhang L; Yang C
    Theranostics; 2020; 10(25):11622-11636. PubMed ID: 33052237
    [No Abstract]   [Full Text] [Related]  

  • 42. MiR-155 regulates lymphoma cell proliferation and apoptosis through targeting SOCS3/JAK-STAT3 signaling pathway.
    Li XD; Li XM; Gu JW; Sun XC
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5153-5159. PubMed ID: 29228427
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphoma.
    Lam LT; Wright G; Davis RE; Lenz G; Farinha P; Dang L; Chan JW; Rosenwald A; Gascoyne RD; Staudt LM
    Blood; 2008 Apr; 111(7):3701-13. PubMed ID: 18160665
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The rGel/BLyS fusion toxin inhibits STAT3 signaling via down-regulation of interleukin-6 receptor in diffuse large B-cell lymphoma.
    Lyu MA; Sung B; Cheung LH; Marks JW; Aggarwal BB; Aguiar RC; Rosenblum MG
    Biochem Pharmacol; 2010 Nov; 80(9):1335-42. PubMed ID: 20654581
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Selective JAK2 inhibition specifically decreases Hodgkin lymphoma and mediastinal large B-cell lymphoma growth in vitro and in vivo.
    Hao Y; Chapuy B; Monti S; Sun HH; Rodig SJ; Shipp MA
    Clin Cancer Res; 2014 May; 20(10):2674-83. PubMed ID: 24610827
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PIM inhibitor SMI-4a induces cell apoptosis in B-cell acute lymphocytic leukemia cells via the HO-1-mediated JAK2/STAT3 pathway.
    Kuang X; Xiong J; Wang W; Li X; Lu T; Fang Q; Wang J
    Life Sci; 2019 Feb; 219():248-256. PubMed ID: 30658101
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MicroRNA-26a/cyclin-dependent kinase 5 axis controls proliferation, apoptosis and in vivo tumor growth of diffuse large B-cell lymphoma cell lines.
    Farina FM; Inguscio A; Kunderfranco P; Cortesi A; Elia L; Quintavalle M
    Cell Death Dis; 2017 Jun; 8(6):e2890. PubMed ID: 28640256
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CDC6, a key replication licensing factor, is overexpressed and confers poor prognosis in diffuse large B-cell lymphoma.
    Shen M; Zhang Y; Tang L; Fu Q; Zhang J; Xu Y; Zeng H; Li Y
    BMC Cancer; 2023 Oct; 23(1):978. PubMed ID: 37833632
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dimethyl fumarate induces ferroptosis and impairs NF-κB/STAT3 signaling in DLBCL.
    Schmitt A; Xu W; Bucher P; Grimm M; Konantz M; Horn H; Zapukhlyak M; Berning P; Brändle M; Jarboui MA; Schönfeld C; Boldt K; Rosenwald A; Ott G; Grau M; Klener P; Vockova P; Lengerke C; Lenz G; Schulze-Osthoff K; Hailfinger S
    Blood; 2021 Sep; 138(10):871-884. PubMed ID: 33876201
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Convallatoxin promotes apoptosis and inhibits proliferation and angiogenesis through crosstalk between JAK2/STAT3 (T705) and mTOR/STAT3 (S727) signaling pathways in colorectal cancer.
    Zhang ZH; Li MY; Wang Z; Zuo HX; Wang JY; Xing Y; Jin C; Xu G; Piao L; Piao H; Ma J; Jin X
    Phytomedicine; 2020 Mar; 68():153172. PubMed ID: 32004989
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling.
    Zhu F; Dai C; Fu Y; Loo JF; Xia D; Gao SP; Ma Z; Chen Z
    Oncotarget; 2016 Feb; 7(8):9462-76. PubMed ID: 26843613
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of the JAK2/STAT3 signaling pathway exerts a therapeutic effect on osteosarcoma.
    Yan J; Wang Q; Zou K; Wang L; Schwartz EB; Fuchs JR; Zheng Z; Wu J
    Mol Med Rep; 2015 Jul; 12(1):498-502. PubMed ID: 25760445
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 4-Methoxydalbergione suppresses growth and induces apoptosis in human osteosarcoma cells in vitro and in vivo xenograft model through down-regulation of the JAK2/STAT3 pathway.
    Park KR; Yun HM; Quang TH; Oh H; Lee DS; Auh QS; Kim EC
    Oncotarget; 2016 Feb; 7(6):6960-71. PubMed ID: 26755649
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
    Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
    Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma.
    Zhang T; Guan XW; Gribben JG; Liu FT; Jia L
    Cell Death Dis; 2019 Apr; 10(5):330. PubMed ID: 30988279
    [TBL] [Abstract][Full Text] [Related]  

  • 56. TIMD4 exhibits regulatory capability on the proliferation and apoptosis of diffuse large B-cell lymphoma cells via the Wnt/β-catenin pathway.
    Li Y; Zhang PY; Yang ZW; Ma F; Li FX
    J Gene Med; 2020 Aug; 22(8):e3186. PubMed ID: 32187802
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel cyclophosphamide of natural products osalmide and pterostilbene induces cytotoxicity and cell cycle arrest in diffuse large B-cell lymphoma cells.
    Xi M; He W; Li B; Zhou J; Xu Z; Wu H; Zhang Y; Song D; Hu L; Lu Y; Bu W; Kong Y; Chen G; Chang S; Shi J; Zhu W
    Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):401-410. PubMed ID: 32259210
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Elevated serum IL-10 levels in diffuse large B-cell lymphoma: a mechanism of aberrant JAK2 activation.
    Gupta M; Han JJ; Stenson M; Maurer M; Wellik L; Hu G; Ziesmer S; Dogan A; Witzig TE
    Blood; 2012 Mar; 119(12):2844-53. PubMed ID: 22323454
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Napabucasin, a novel inhibitor of STAT3, inhibits growth and synergises with doxorubicin in diffuse large B-cell lymphoma.
    Li X; Wei Y; Wei X
    Cancer Lett; 2020 Oct; 491():146-161. PubMed ID: 32798587
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quercetin potentiates the antitumor activity of rituximab in diffuse large B-cell lymphoma by inhibiting STAT3 pathway.
    Li X; Wang X; Zhang M; Li A; Sun Z; Yu Q
    Cell Biochem Biophys; 2014 Nov; 70(2):1357-62. PubMed ID: 24902540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.